## Abstract Cellular cytotoxicity reactions to human leukemia cells were measured with a sensitive, quantitative assay of cell‐mediated immunity. Freshly explanted leukemia cells, rather than tissue culture cells, were tested to ensure that the antigens detected were not acquired in vitro. Identica
Failure to demonstrate immunity to leukemia associated antigens by lymphocyte transformation in vitro
✍ Scribed by Marjan Schweitzer; C. J. M. Melief; V. P. Eijsvoogel
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- French
- Weight
- 503 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Mixed cultures of leukemic cells from acute lymphatic leukemia patients with autologous remission lymphocytes and of leukemic cells from both acute lymphatic leukemia patients and chronic lymphocytic leukemia patients with the lymphocytes from an HL‐A identical sibling were performed to investigate whether sensitization against leukemia‐associated antigens was demonstrable. Although in some cases marked thymidine incorporation was measured, this cannot be interpreted as stimulation by leukemia‐associated antigens, because it cannot be distinguished from non‐specific thymidine incorporation as was shown to occur sometimes in unstimulated cultures. It is concluded that the lymphocyte transformation technique is unsuitable for the detection of immunity to leukemia‐associated antigens.
📜 SIMILAR VOLUMES
## Abstract Cell‐mediated immunity (CMI) and tumor rejection were studied in the Friend virus leukemia system of C57BI/6 mice. Mice were immunized with Friend leukemia virus (FLV) or X‐irradiated FBL‐3 leukemic cells and studied temporally for the development of CMI reactivity by assays of ^51^Cr r
## Abstract In vitro inhibition of monocyte spreading (a correlate of cellular immunity) was used to detect cell‐mediated immune reactions of melanoma patients to specific melanoma antigens. Two soluble preparations of human melanoma antigens (MA‐1 and MA‐2) and one of a breast carcinoma (BCA) were